BiogenBIIB 
$197.53-0.34%24h
-0.34%24h
Global rank648
Market cap$28.58B
Change 7d0.14%
YTD Performance-23.31%
SP500 benchmarkUnderperform
P/E24.78
P/S2.91
Revenue$9.84B
Earnings$1.16B
Dividend yield-
Main Sector
Healthcare
Category
Biogen (BIIB) Cash on Hand
BIIB Cash on Hand in 2022: $1.05B
According to Biogen latest financial reports the cash on hand of BIIB is $1.05B, an decrease of -78.54% to 2022. At the end of 2022 company had $4.89B cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
BIIB Cash on Hand History from 2018 to 2023
-
Value:-
BIIB Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $1.05B | -78.54% |
| 2022 | $4.89B | 28.67% |
| 2021 | $3.80B | 45.68% |
| 2020 | $2.61B | -41.69% |
| 2019 | $4.48B | 26.51% |
| 2018 | $3.54B | - |
View the Top Cash on Hand Companies 
